Powder: -20°C for 3 years | In solvent: -80°C for 1 year
GSK251 is a novel, orally bioavailable inhibitor of PI3Kδ, exhibiting high potency and selectivity, with a unique binding mode.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
1 mg | 在庫あり | ¥ 64,000 |
5 mg | 在庫あり | ¥ 159,500 |
10 mg | 在庫あり | ¥ 227,000 |
25 mg | 在庫あり | ¥ 337,500 |
50 mg | 在庫あり | ¥ 454,500 |
100 mg | 在庫あり | ¥ 613,000 |
説明 | GSK251 is a novel, orally bioavailable inhibitor of PI3Kδ, exhibiting high potency and selectivity, with a unique binding mode. |
分子量 | 584.71 |
分子式 | C29H37FN6O4S |
CAS No. | 2125968-05-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (85.5 mM), Sonication and heating to 60℃ are recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
GSK251 2125968-05-8 PI3K/Akt/mTOR signaling PI3K GSK 251 GSK-251 Inhibitor inhibitor inhibit